Eton Pharmaceuticals (ETON) EPS (Basic) Growth (1y) (2019 - 2026)
Eton Pharmaceuticals (ETON) EPS (Basic) Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.40 Bn | 43.44 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.69 Bn | 40.03 Bn | 2.15 Bn | -301.82% |
| 3 | Zoetis | 32.50 Bn | 30.83 Bn | 1.05 Bn | 1.21% |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -17.09% |
| 5 | United Therapeutics | 22.10 Bn | 19.44 Bn | 683.80 Mn | 13.91% |
| 6 | Viatris | 18.92 Bn | 18.03 Bn | 1.46 Bn | -2,504.14% |
| 7 | Neurocrine Biosciences | 15.47 Bn | 15.08 Bn | 935.80 Mn | 31.67% |
| 8 | Elanco Animal Health | 11.99 Bn | 11.46 Bn | 798.00 Mn | 388.06% |
| 9 | Dr Reddys Laboratories | 10.15 Bn | 9.99 Bn | - | - |
| 10 | Eton Pharmaceuticals | 1.71 Bn | 1.68 Bn | 25.41 Mn | 535.76% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 535.65% |
| Dec 31, 2025 | 372.94% |
| Sep 30, 2025 | -100.30% |
| Jun 30, 2025 | 100.00% |
| Mar 31, 2025 | 99.81% |
| Dec 31, 2024 | 68.23% |
| Sep 30, 2024 | 107,633.38% |
| Jun 30, 2024 | -66,324.52% |
| Mar 31, 2024 | -30,107.07% |
| Dec 31, 2023 | -165.14% |
| Sep 30, 2023 | 81.25% |
| Jun 30, 2023 | 100.29% |
| Mar 31, 2023 | 50.53% |
| Dec 31, 2022 | 170.73% |
| Sep 30, 2022 | 50.21% |
| Jun 30, 2022 | -77,444.04% |
| Mar 31, 2022 | -200.69% |
| Dec 31, 2021 | 111.27% |
| Sep 30, 2021 | 21.96% |
| Jun 30, 2021 | 99.96% |